Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates
Go back to Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates| (NASDAQ: VRDN) | Delayed: 21.81 -0.19 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.00 | 52 Week High | $ | |||
| Open | $22.28 | 52 Week Low | $ | |||
| Day High | $22.40 | P/E | N/A | |||
| Day Low | $21.63 | EPS | $ | |||
| Volume | 722,137 | |||||

